Orris
attachment

Today is my jc presentation in my seminar room and i an pg 2 in general surgery department and this this my 1 st page of ppt … suggest me questions which can be asked by my professor so that i can answer them all

Reading File
Checking Date & Time
Good luck, Dr. Khushi! Here's a comprehensive set of questions Prof. Dr. Naveenkumar Singh Sir is likely to ask, organized by category — with brief model answers so you're fully prepared.

🔷 About the Paper Itself

Q1. Why did you choose this paper for journal club? → It's a 2026 SSAT state-of-the-art systematic review + meta-analysis — highest level of evidence on subtotal cholecystectomy (STC), directly relevant to difficult gallbladder cases we encounter in general surgery.
Q2. What is the impact factor of Journal of Gastrointestinal Surgery? → ~3.5–4 (high-impact HPB surgery journal). Be ready to say: "It's indexed in PubMed and is the official journal of SSAT."
Q3. What does SSAT stand for? → Society for Surgery of the Alimentary Tract.
Q4. What level of evidence is this study? → Level I evidence — systematic review and meta-analysis.

🔷 Fundamentals — Subtotal Cholecystectomy

Q5. What is subtotal cholecystectomy? Define it. → Intentional incomplete removal of the gallbladder where the infundibulum/posterior wall is left in situ due to inability to safely achieve the Critical View of Safety (CVS). The cystic duct is either ligated or left open.
Q6. What are the two types of subtotal cholecystectomy? →
  • Reconstituting (Type A): Cystic duct ligated, gallbladder remnant closed — can reform a gallbladder-like pouch.
  • Fenestrating (Type B): Gallbladder opened, cystic duct NOT closed, remaining mucosa ablated — bile drains freely into peritoneum initially.
Q7. When do you decide to do STC intraoperatively? → When the Critical View of Safety (CVS) cannot be achieved due to:
  • Severe acute/chronic inflammation (frozen Calot's)
  • Mirizzi syndrome
  • Cirrhosis with portal hypertension
  • Dense adhesions obscuring hepatocystic triangle

🔷 Critical View of Safety (CVS)

Q8. What is the Critical View of Safety? Who described it? → Described by Strasberg (1995). Two criteria:
  1. Hepatocystic triangle cleared of fat and fibrous tissue
  2. Lower one-third of gallbladder separated from liver bed → Only TWO structures (cystic duct + cystic artery) enter the gallbladder.
Q9. If CVS cannot be achieved, what are your options? →
  1. Subtotal cholecystectomy
  2. Top-down (fundus-first) cholecystectomy
  3. Conversion to open
  4. Cholecystostomy tube (damage control)
  5. Bail-out laparotomy

🔷 Bailout Strategies — "Bailout or Burden" Theme

Q10. Why is STC called a "bailout" procedure? → It is performed to avoid bile duct injury (BDI) when dissection in Calot's triangle is unsafe — it "bails out" the surgeon from a dangerous situation.
Q11. Why could it be a "burden"? → Because of associated morbidity:
  • Bile leak (from cystic duct stump / open fenestration)
  • Residual gallstone disease
  • Post-operative biliary fistula
  • Need for re-operation / ERCP
  • Retained cystic duct stump syndrome
Q12. What is the bile leak rate after STC vs. total cholecystectomy? → STC has significantly higher bile leak rates (~10–20% for fenestrating type vs. <1% for standard laparoscopic cholecystectomy). This is a key finding of such meta-analyses.

🔷 Complications & Management

Q13. How do you manage a post-STC bile leak? →
  • ERCP + biliary stenting (first-line for most)
  • Percutaneous drainage if bile collection
  • Re-operation if above fails or for peritonitis
Q14. What is Mirizzi syndrome? How does it relate to STC? → Extrinsic compression of the common hepatic duct by a stone impacted in the Hartmann's pouch/cystic duct. High-grade Mirizzi (Type III/IV) often mandates STC as total cholecystectomy risks CHD injury.
Q15. What is cystic duct stump syndrome? → Symptomatic retained cystic duct stump (>1 cm) post-cholecystectomy causing right upper quadrant pain, biliary colic, or cholangitis — may harbor residual stones.

🔷 Bile Duct Injury (BDI)

Q16. What is the incidence of BDI in laparoscopic cholecystectomy? → ~0.3–0.6% (higher than open cholecystectomy ~0.1–0.2%).
Q17. What is the Strasberg-Bismuth classification of BDI? →
  • Strasberg A: Cystic duct or minor duct leak
  • B/C: Occlusion/leakage of aberrant duct
  • D: Lateral injury to major duct
  • E1–E5: Bismuth-type injuries (transection of CBD at various levels)
Q18. Does STC reduce BDI compared to persisting with difficult total cholecystectomy? → YES — that is the core premise of STC. Recognizing when to stop prevents catastrophic BDI. The meta-analysis likely shows BDI rate with STC is near zero when the decision is made appropriately.

🔷 Laparoscopic vs. Open STC

Q19. Can STC be completed laparoscopically? → Yes. Laparoscopic STC is increasingly described, though conversion rates are higher in the difficult gallbladder. The meta-analysis may compare laparoscopic vs. open outcomes.
Q20. What are the advantages of laparoscopic approach even for STC? → Less wound morbidity, faster recovery, reduced SSI — outcomes favorable even when total removal not achieved laparoscopically.

🔷 Methodology Questions (Meta-Analysis Specific)

Q21. What is a systematic review vs. meta-analysis? → Systematic review: structured literature synthesis following PRISMA guidelines. Meta-analysis: statistical pooling of quantitative data from multiple studies to generate a combined effect estimate.
Q22. What is heterogeneity in a meta-analysis? How is it measured? → Variability in results across studies. Measured by I² statistic:
  • <25%: low heterogeneity
  • 25–75%: moderate
  • 75%: high
Q23. What is publication bias? How do you check for it? → Tendency for positive studies to be published over negative ones. Assessed by funnel plots and Egger's test.
Q24. What are the limitations of this meta-analysis you'd anticipate? →
  • Heterogeneous definitions of STC across studies
  • Variability in surgeon experience
  • Retrospective study designs in included papers
  • Selection bias (STC chosen in more severe cases)
  • No standardized follow-up period

🔷 Clinical Scenario Questions

Q25. You are operating a 45-year-old patient with acute cholecystitis and dense adhesions in Calot's. What do you do? → Attempt to achieve CVS. If unable after reasonable dissection → perform subtotal fenestrating cholecystectomy. Leave drain. Post-op ERCP if bile leak develops.
Q26. When would you place a cholecystostomy tube instead of STC? → In critically ill patients (septic, coagulopathic) unfit for general anaesthesia — cholecystostomy as bridge to definitive surgery.

🔷 Closing Questions

Q27. What is the "Tokyo Guidelines" and how do they relate to this topic? → TG18/TG13 guidelines grade acute cholecystitis (I/II/III) and recommend timing/approach. Grade III (severe) cases are most likely to need STC.
Q28. What is your take-home message from this paper? → STC is a safe, intentional, evidence-based bailout strategy that significantly reduces catastrophic BDI risk in the difficult gallbladder. Fenestrating type carries higher bile leak risk but is manageable. Surgeons should recognize its limitations early rather than persist dangerously.

Pro Tips for Your Presentation

  • Know your forest plot — be able to explain pooled odds ratio, 95% CI, and what each study in the plot represents
  • Anticipate: "What would you do differently in your own department?"
  • When unsure, say: "The paper doesn't specifically address that, but based on evidence, I would..."
Best of luck, Dr. Khushi! You've got this. 💪
This is a shared conversation. Sign in to Orris to start your own chat.